VANCOUVER, BC / / July 7, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC:XPHYF)(FSE:4XT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to ...

Pre-study validation of the method was performed by documentation of specificity, linearity, limit of quantification, precision and accuracy.

Subsequently, the developed methodology was applied in a bioequivalence study involving anemia patients. The in-study quality control results demonstrated that the method was highly accurate, with ...

In conclusion, this study reveals important flaws in the current design and analysis of single-dose crossover studies currently used to assess the bioequivalence of LT 4 products.

ABSTRACT: Background: This study evaluated the bioequivalence of empagliflozin 12.5 mg/metformin 1000 mg tablets compared to Synjardy® (Empagliflozin 12.5 mg/metformin 1000 mg) tablets in healthy male ...

ABSTRACT BACKGROUND AND OBJECTIVES: The objective of this study was to assess the bioequivalence between two 200 mg celecoxib hard capsule formulations administered to healthy male and female ...

LTR Pharma (ASX:LTP) begins patient recruitment for clinical study into SPONTAN® described as world first treatment for erectile dysfunction.

Abstract Objectives: Evaluate the bioequivalence (BE) of two oral tablets formulations of diclofenac 150 mg in healthy male subjects under fasting condition. This was a phase I, randomized, open label ...